Cumberland Pharmaceuticals (CPIX) Depreciation & Amortization (CF) (2010 - 2026)

Cumberland Pharmaceuticals has reported Depreciation & Amortization (CF) for 17 years, with the latest figure at $1.3 million in Q1 2026.

• Quarterly Depreciation & Amortization (CF) rose 23.72% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (down 8.23% YoY) and the FY2025 annual result came in at $4.1 million, down 15.45% from the prior year.
• Depreciation & Amortization (CF) advanced to $1.3 million in Q1 2026 per CPIX's latest filing, from $1.0 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $1.7 million in Q1 2022 and troughed at $511483.0 in Q4 2022.
• A 5-year average of $1.2 million and a median of $1.2 million in 2023 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) tumbled 52.51% in 2022, then surged 141.12% in 2023.
• Over 5 years, Depreciation & Amortization (CF) stood at $511483.0 in 2022, then soared by 141.12% to $1.2 million in 2023, then advanced by 21.34% to $1.5 million in 2024, then tumbled by 30.37% to $1.0 million in 2025, then advanced by 22.5% to $1.3 million in 2026.
• According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $1.3 million, $1.0 million, and $1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.